Clinical Trials Logo

Acute Pain clinical trials

View clinical trials related to Acute Pain.

Filter by:

NCT ID: NCT04834427 Enrolling by invitation - Postoperative Pain Clinical Trials

Safety and Efficacy Evaluation of S (+) - Ketamine in Children

Start date: April 20, 2022
Phase: Phase 4
Study type: Interventional

A multicenter, randomized, open-label, active controlled pragmatic clinical trial that evaluates the safety and efficacy of S (+) -ketamine for postoperative acute pain in children in perioperative settings.

NCT ID: NCT04829409 Recruiting - Pain, Acute Clinical Trials

The Effects of Three Different Ultrasound-guided Nerve Blocks in VATS

Start date: April 5, 2021
Phase: N/A
Study type: Interventional

Ultrasound-guided mid-point transverse process to pleura block, erector spinae plane block and paravertebral block are three different methods of nerve block, used for relieving postoperative pain in thoracic anesthesia. This study is to compare them on block effects, postoperative pain and analgesic consumption in video-assisted thoracic surgery.

NCT ID: NCT04822311 Completed - Depression Clinical Trials

Evaluating the Impact of Focused Muscle Contraction Therapy in Retire APF Players

GH-APF
Start date: October 24, 2019
Phase: N/A
Study type: Interventional

This study will investigate the effects of an exercise intervention on retired American professional football (APF) players. A total of 20 retired APF players (≥ 18 years of age), who suffer from chronic pain, will be enrolled. The study duration for each participants will be 18 months. Enrolled participants will perform a 18 months exercise intervention which involves 90 exercise rehabilitation training visits. In addition, participants will also be tested on various measures of health and function both at baseline (prior to intervention), at 6 months, 12 months, and 18 months (post intervention). All testing and result interpretation will be performed by trained research personnel. Participants are not University of Illinois at Chicago (UIC) participants; however, study testing visits will occur at UIC. All exercise intervention training visits will occur at Gh Fitlab.

NCT ID: NCT04812860 Active, not recruiting - Clinical trials for Moderate to Severe Acute Pain

A Study to Evaluate the Efficacy and Safety of HR18042 Tablets in the Treatment of Postoperative Pain of Impacted Tooth.

Start date: December 8, 2020
Phase: Phase 2
Study type: Interventional

The purpose of this study was to evaluate the Efficacy and safety of HR18042 tablets for the Treatment of Post-surgical Pain After extraction of impacted tooth, find the optimal dose.

NCT ID: NCT04811209 Not yet recruiting - Pain Management Clinical Trials

MCID and PASS for Acute Pain and Quality of Recovery After Orthopedic Surgery

Start date: April 2021
Phase:
Study type: Observational

This study seeks to define what constitutes an MCID and a PASS in patients undergoing a variety of elective major orthopedic surgery.

NCT ID: NCT04799041 Completed - Acute Pain Clinical Trials

Gonyautoxin 2/3 in the Treatment of Acute Back Pain: A Clinical Proof-of-concept Study

Start date: October 11, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

This was an interventional, double-blind, placebo controlled, randomized, single dose, proof-of-concept study. It was a single-center clinical trial. The purpose of the study was to explore the clinical efficacy and safety of a single local IM injection of gonyautoxin 2/3 (GTX 2/3) compared to placebo in decreasing pain and improving lumbar functionality at short term follow-up in adult patients with acute low back pain, without radiculopathy.

NCT ID: NCT04787198 Recruiting - Pain, Acute Clinical Trials

Investigating Composite Biomarkers for Pain Catastrophizing

Start date: October 15, 2022
Phase: N/A
Study type: Interventional

Pain is a complex, multidimensional, and subjective experience; and although, investigators use a single word "pain", to describe our perception, multiple mechanisms contribute to the generation and maintenance of pain. To help diagnosing and improving pain management, there is a need for developing tools. These tools may include measurements of substances, or biomarkers, in the blood; e.g. small molecules called microRNA and proteins. In these experiments, the investigators would like to investigate how the psychological response to stress and pain alters the impulses in the brain and the content of microRNA and proteins in the blood. The future aim is to identify patients in high risk of developing and maintaining chronic pain and to be able to treat chronic pain efficiently.

NCT ID: NCT04786405 Completed - Clinical trials for Mindfulness Meditation

Mindfulness Meditation Versus Clinical Hypnosis for Acute, Experimental Pain

Start date: March 15, 2021
Phase: Phase 2
Study type: Interventional

This trial aims to determine the effects and mechanisms (mediators and moderators) of brief training in mindfulness meditation versus clinical hypnosis on acute, experimental pain.

NCT ID: NCT04779567 Completed - Acute Pain Clinical Trials

Usefulness of Acetaminophen Associated With Strong Opioids for Acute Pain in Cancer Patients

Start date: June 10, 2019
Phase: Phase 4
Study type: Interventional

Cancer pain is one of the most frequent and relevant symptoms in cancer patients and has a great impact on a patient's quality of life. International and local standards recommend as an initial strategy, the use of an analgesic scheme composed of strong opioids (morphine, methadone or fentanyl) associated with adjuvants such as paracetamol, based upon the assumption that the use of combined analgesics could have a better analgesic effect, could allow the use of lower dose of opioids and that also could prevent the occurrence of adverse effects of opioids. However, there is uncertainty about the impact of paracetamol as an adjuvant in patients who use strong opioids for pain management in cancer patients with moderate to severe pain. To clarify this question, this study aims to evaluate the efficacy and safety of intravenous paracetamol associated with strong opioids in hospitalized cancer patients who have pain associated with cancer of moderate to severe intensity, (4 or more), older than 18 years. Randomized double-blinded controlled study comparing intravenous acetaminophen 1 gr 4 times a day versus placebo for 48 hours as an adjuvant to strong opioids. We will assess pain intensity as a primary outcome validated assessments that estimate Verbal Numerical Rating Scale (VNRS) analogous verbal pain from 0 to 10, and de visual Analog Scale (VAS). We estimated that a decrease of 1 point on the verbal numerical scale would be statistically significant. In addition, the investigators will calculate the amount of total opioid dose in 24 hours and then perform the intervention. As a secondary outcome, adverse effects such as drowsiness, constipation, nausea and vomiting would be evaluated

NCT ID: NCT04774783 Recruiting - Chronic Pain Clinical Trials

Pilot Study on the Effects of Low-Level Laser Therapy Treatment for Acute and Persistent Discomfort

Start date: February 22, 2021
Phase: N/A
Study type: Interventional

This study will examine the effectiveness of Low-Level Laser Therapy (LLLT) for the management of pain in various locations of the body. All subjects selected for participation in the study will be assigned to a LLLT treatment group for a duration of 12 sessions.